You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

ISORDIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Isordil patents expire, and when can generic versions of Isordil launch?

Isordil is a drug marketed by Wyeth Ayerst, Bausch, and Biovail. and is included in three NDAs.

The generic ingredient in ISORDIL is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Isordil

A generic version of ISORDIL was approved as isosorbide dinitrate by PAR PHARM on March 12th, 1987.

  Try a Trial

Drug patent expirations by year for ISORDIL
Drug Prices for ISORDIL

See drug prices for ISORDIL

Recent Clinical Trials for ISORDIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Children's Hospital Medical Center, CincinnatiPhase 2
Brigham and Women's HospitalPhase 4
Momentum Research, Inc.Phase 3

See all ISORDIL clinical trials

Pharmacology for ISORDIL
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for ISORDIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst ISORDIL isosorbide dinitrate CAPSULE, EXTENDED RELEASE;ORAL 012882-002 Jul 29, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bausch ISORDIL isosorbide dinitrate TABLET;ORAL 012093-001 Jul 29, 1988 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bausch ISORDIL isosorbide dinitrate TABLET;ORAL 012093-002 Jul 29, 1988 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.